Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.59%204.730.0%$1953.60m
NVAXNovavax, Inc. -1.39%110.8278.2%$804.64m
AMGNAmgen, Inc. 1.95%235.361.4%$611.59m
BIIBBiogen, Inc. 1.11%239.301.8%$512.74m
GILDGilead Sciences, Inc. -0.15%71.771.0%$503.51m
BNTXBioNTech SE -3.44%196.000.0%$496.41m
ILMNIllumina, Inc. 1.41%405.143.3%$455.30m
REGNRegeneron Pharmaceuticals, Inc. -0.14%615.242.7%$435.16m
VRTXVertex Pharmaceuticals, Inc. 3.30%234.061.9%$373.05m
SNSSSunesis Pharmaceuticals, Inc. 2.26%3.170.7%$221.59m
INCYIncyte Corp. 1.67%74.882.4%$172.85m
EXASEXACT Sciences Corp. 4.02%78.4318.0%$156.45m
ARNAArena Pharmaceuticals, Inc. 0.20%92.6513.7%$151.27m
ALNYAlnylam Pharmaceuticals, Inc. 0.34%148.508.2%$147.48m
BMRNBioMarin Pharmaceutical, Inc. 2.34%90.224.2%$114.62m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.